Endocardial fibroelastosis (EFE) is a rare cardiac condition which is classically described in the paediatric population (typically first two years). It is one of the causes for infants to present with unexplained heart failure.
The condition results from increasing amounts of fibrous and elastic tissue affecting the endocardium as well as the sub endocardium. This then causes diffuse thickening with subsequent impairment of myocardial contractility.
- mitral valve abnormalities: e.g mitral regurgitation
- hypoplastic left heart syndrome: along the wall of the hypoplastic left ventricle
- Barth syndrome
Echocardiography may show:
- 1. Mcgahan JP. Sonography of the fetal heart: findings on the four-chamber view. AJR Am J Roentgenol. 1991;156 (3): 547-53. AJR Am J Roentgenol (abstract) - Pubmed citation
- 2. Fetal endocardial fibroelastosis: ultrasonographic findings in two cases Tannouri et al. J Ultrasound Med.1998; 17: 63-66
- 3. Weiner, Zeev MD; Shalev, Eliezer MD, Case Reports Doppler Fetal Echocardiography in Endocardial Fibroelastosis, Obstetrics & Gynecology: November 2001 - Volume 98 - Issue 5, Part 2 - p 933-935
- 4. Soon Yong Suha et.al, Endocardial fibroelastosis demonstrated on multidetector computed tomography, Volume 124, Issue 3, Pages e51-e52 (14 March 2008)
- 5. Lynne E. Nield, MD et.al, CLINICAL STUDY: ENDOCARDIAL FIBROELASTOSIS, Endocardial fibroelastosis associated with maternal anti-Ro and anti-La antibodies in the absence of atrioventricular block, J Am Coll Cardiol, 2002; 40:796-802